Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,240.00
Bid: 1,240.00
Ask: 1,245.00
Change: -37.00 (-2.90%)
Spread: 5.00 (0.403%)
Open: 1,277.00
High: 1,284.00
Low: 1,240.00
Prev. Close: 1,277.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

1 Sep 2022 07:00

RNS Number : 8277X
Indivior PLC
01 September 2022
 

INDIVIOR PLC

TRANSACTIONS IN OWN SHARES

September 1, 2022

INDIVIOR PLC ("Indivior") announces that on August 31, 2022 it purchased for cancellation the following number of its ordinary shares of $0.10 each through Stifel Nicolaus Europe Limited.

Ordinary Shares

Date of purchases:

August 31, 2022

Number of ordinary shares purchased:

23,655

Highest Price per share:

294.60

Lowest Price per share:

282.80

Volume Weighted Average Price per day per trading venue:

287.70

Indivior intends to cancel all of the purchased shares.

All repurchases by Indivior are "On Exchange" transactions (as such term is defined in the rules of the London Stock Exchange) and "on market" for the purposes of the Companies Act 2006.

Following the above transaction and cancellation of the purchased shares, Indivior has 692,075,289 ordinary shares with voting rights in issue. There are no ordinary shares held in treasury.

The above figure (692,075,289) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Indivior under the FCA's Disclosure Guidance and Transparency Rules.

Aggregated information

Trading Venue

Aggregated volume (shares)

Volume weighted average price (p)

CHIX

8,132

288.4917

AQXE

866

288.3263

BATE

2,483

285.3161

XLON

12,174

287.6058

 

Contact:

Jason Thompson

Vice President, Investor Relations

1-804-402-7123

Transaction details

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014, as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, a full breakdown of the individual purchases of ordinary shares made by Stifel Nicolaus Europe Limited on behalf of Indivior as part of the Share Repurchase Program is detailed below.

Time

Price (p)

Quantity

Venue

Reference

08:14:40

294.6

479

CHIX

00030564678TRLO0

 08:14:40

294.6

400

CHIX

00030564679TRLO0

 08:14:40

294.6

800

CHIX

00030564680TRLO0

 08:14:40

294.6

6

CHIX

00030564681TRLO0

 08:43:03

291

145

AQXE

00030565441TRLO0

 08:43:03

291

40

AQXE

00030565442TRLO0

 08:49:40

289.8

862

XLON

00030565568TRLO0

 08:49:40

289.8

152

XLON

00030565569TRLO0

 08:49:40

289.8

650

XLON

00030565570TRLO0

 09:44:34

289.6

780

XLON

00030566591TRLO0

 09:44:34

289.6

800

XLON

00030566592TRLO0

 09:44:34

289.6

97

XLON

00030566593TRLO0

 10:19:38

287.6

681

AQXE

00030567169TRLO0

 10:40:48

283

1418

BATE

00030567646TRLO0

 10:40:48

282.8

1689

XLON

00030567647TRLO0

 12:24:26

288

745

XLON

00030570053TRLO0

 12:25:17

288

801

XLON

00030570062TRLO0

 12:25:19

288

3

XLON

00030570063TRLO0

 13:12:40

288.6

1445

XLON

00030570786TRLO0

 13:47:28

287.6

1646

CHIX

00030571228TRLO0

 14:16:57

285.8

1641

CHIX

00030571917TRLO0

 14:41:01

287

1722

XLON

00030572457TRLO0

 15:06:43

287

1628

CHIX

00030573123TRLO0

 15:36:38

287.2

890

CHIX

00030576651TRLO0

 15:36:38

287.2

642

CHIX

00030576652TRLO0

 15:54:27

287.8

1542

XLON

00030577326TRLO0

 16:14:11

287.4

886

XLON

00030578244TRLO0

 16:19:12

288.4

212

BATE

00030578463TRLO0

 16:19:12

288.4

412

BATE

00030578464TRLO0

 16:19:12

288.4

400

BATE

00030578465TRLO0

 16:19:12

288.4

41

BATE

00030578466TRLO0

 

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGZGFRVMLGZZM
Date   Source Headline
31st Jul 20187:00 amRNSIndivior Preliminary Injunction Upheld
30th Jul 20187:01 amRNSDRL's Appeal of Indivior's PI Granted-in-Part
30th Jul 20187:00 amRNSUS FDA Approves Indivor's PERSERIS(TM)
27th Jul 20188:40 amRNSHolding(s) in Company
26th Jul 20189:01 amRNSHolding(s) in Company
25th Jul 20187:00 amRNSHalf-year Report
24th Jul 20187:00 amRNSHolding(s) in Company
16th Jul 20187:00 amRNSUS Court Grants Indivior Preliminary Injunction
13th Jul 20184:39 pmRNSHolding(s) in Company
12th Jul 20185:16 pmRNSHolding(s) in Company
11th Jul 20187:00 amRNSIndivior Sees FY18 Guidance Below Expectations
10th Jul 20187:00 amRNSNotice of Results
3rd Jul 20187:01 amRNSHolding(s) in Company
3rd Jul 20187:00 amRNSHolding(s) in Company
29th Jun 20187:00 amRNSIndivior's Temporary Restraining Order is Extended
21st Jun 20182:56 pmRNSHolding(s) in Company
20th Jun 20187:00 amRNSHolding(s) in Company
18th Jun 20187:00 amRNSIndivior Is Granted Temporary Restraining Order
15th Jun 20183:56 pmRNSHolding(s) in Company
15th Jun 20181:59 pmRNSIndivior Responds to Generic SUBOXONE ® Approvals
7th Jun 20189:30 amRNSHolding(s) in Company
1st Jun 20187:00 amRNSTotal Voting Rights
31st May 20187:00 amRNSCalifornia Department of Insurance subpoena
25th May 20182:25 pmRNSSUBLOCADE(TM) Submitted in Australia for Approval
24th May 20187:00 amRNSIndivior Participating in Jefferies NYC Conference
16th May 20185:50 pmRNSResult of AGM
14th May 20187:00 amRNSIndivior settlement with Par Pharmaceutical
10th May 201811:40 amRNSBlock listing Interim Review
4th May 20182:13 pmRNSDirector/PDMR Shareholding
2nd May 20187:00 amRNS1st Quarter Results
20th Apr 20187:00 amRNSIndivior's SUBLOCADE NDS Accepted by Health Canada
12th Apr 20183:56 pmRNSHolding(s) in Company
11th Apr 20184:02 pmRNSDirector Declaration
11th Apr 20187:00 amRNSNotice of Results
6th Apr 20189:31 amRNSHolding(s) in Company
5th Apr 20187:00 amRNSIndivior Asserts New SUBOXONE(R) Film Patent
4th Apr 20189:28 amRNSDirector/PDMR Shareholding
3rd Apr 20189:33 amRNSHolding(s) in Company
3rd Apr 20187:00 amRNSTotal Voting Rights
29th Mar 20187:00 amRNSIndivior and C4X Enter Licensing Agreement
27th Mar 20184:13 pmRNSHolding(s) in Company
23rd Mar 20187:00 amRNSIndivior Responds to Court Ruling ANDA litigation
22nd Mar 20181:39 pmRNSAnnual Financial Report
13th Mar 20183:14 pmRNSDirector/PDMR Shareholding
12th Mar 20184:30 pmRNSDirector/PDMR Shareholding
2nd Mar 20182:51 pmRNSHolding(s) in Company
2nd Mar 201810:24 amRNSHolding(s) in Company
1st Mar 20181:00 pmRNSIndivior Announces SUBLOCADET Available in US
1st Mar 20187:00 amRNSTotal Voting Rights
28th Feb 20185:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.